Materialise NV (NASDAQ:MTLS) Q1 2024 Earnings Conference Call April 25, 2024 8:30 AM ET
Company Participants
Harriet Fried - Lippert/Heilshorn & Associates
Brigitte de Vet - CEO
Koen Berges - CFO
Conference Call Participants
Alexander Craeymeersch - Kepler Cheuvreux
Jacob Stephan - Lake Street Capital Markets
Operator
Good day, and thank you for standing by. Welcome to the Q1 2024 Materialise N.V. Financial Results Conference Call. [Operator Instructions]. Please be advised that today's conference is being recorded. I would now like to hand the conference over to your first speaker today, Harriet Fried of LHA. Please go ahead.
Harriet Fried
Thank you, everyone, for joining us today for Materialise's quarterly conference call. With us on the call are, Brigitte de Vet, Chief Executive Officer; and Koen Berges, Chief Financial Officer. Today's call and webcast are being accompanied by a slide presentation that reviews Materialise's strategic, financial and operational performance for the first quarter of 2024. To access the slides, if you haven't already done so, please go to the Investor Relations section of the company's website at www.materialise.com. The earnings press release that was issued earlier today can also be found on that page. Before we get started, I'd like to remind you that management may make forward-looking statements regarding the company's plans, expectations and growth prospects, among other things. These forward-looking statements are subject to known and unknown uncertainties and risks that could cause actual results to differ materially from the expectations expressed, including competitive, dynamics and industry change. Any forward-looking statements, including those related to the company's future results and activities, represent management's estimates as of today and should not be relied upon as representing their estimates as of any subsequent date.
Management disclaims any duty to update or revise any forward-looking statements to reflect future events or changes in expectations. A more detailed description of the risks and uncertainties and other factors that could impact the company's future business or financial results can be found in the company's most recent annual report on Form 20-F filed with the SEC.
Finally, management will discuss certain non-IFRS measures on today's call. A reconciliation table is contained in the earnings release and at the end of the slide presentation. And now I would like to turn the call over to Brigitte de Vet.
Brigitte de Vet
Good morning, and good afternoon. Thank you, everyone, for joining us today. Looking at the agenda for our call on Slide 3. You will recall that in our last earnings call, I described my observations about the market dynamics and our strong position in this market, built on the foundation of the last 34 years. I also clearly described our priorities for 2024. Today, I will build on that theme and share with you key highlights of our team's performance in the first quarter 2024 as well as the progress made on our strategic priorities. After that, I'll pass the floor to Koen, who will go through our first quarter numbers in more detail. Finally, I will come back and explain what we expect the remaining months of 2024 to bring. And we've completed our prepared remarks, we'll be happy to respond to questions. Looking at our key results for Q1 2024, summarized on Page 4, you can see that we were able to deliver profitable results in line with our expectations. For the comparisons versus the first quarter of last year, on this call, please bear in mind that the first quarter 2023 was a particularly strong quarter with record high revenues and high EBITDA supported by significant tailwinds mainly in our Medical and Manufacturing segments.